The IDCRC announces the upcoming retirement of Jeffery Lennox, MD

Jeff Lennox headshot

The IDCRC LG would like to congratulate Jeff Lennox, MD, on his upcoming retirement on June 30, 2024, from Emory University. Dr. Lennox currently serves as IDCRC LG COU co-director, alongside Robert Atmar, MD, to provide effective operational support, efficient management, and oversight for the LG’s clinical research portfolio. Having served in this role since the IDCRC’s inception, Dr. Lennox has worked closely with the various LG operating units, VTEUs, and DMID to oversee and support the development of approved IDCRC concepts into quality clinical trials.

"It’s been great working with Jeff in the COU over the past five years. He’s been a great partner, and we’re really going to miss him. I wish him the best in his retirement," says Robert Atmar, MD, IDCRC COU co-director.

In addition to his work with the IDCRC, he has been an invaluable contributor to the Emory community as a highly respected investigator, clinician, educator, and leader. He has served as associate dean for clinical research at Emory University School of Medicine since 2010 and as the Department of Medicine's vice chair for Grady Affairs and chief of Emory Medicine Service at Grady Memorial Hospital since 2009. He was the principal investigator for the Emory HIV Clinical Trials Unit from 2007 to 2013 and co-principal investigator for the Emory-CDC HIV/AIDS Clinical Trials Unit from 2013 to 2023. He also served as medical director of the Ponce Grady Infectious Disease Program from 1995 to 2009 and the Emory Infectious Diseases section chief at Grady Memorial Hospital from 2001 to 2012. He was a co-director of the Clinical Research Core for the Emory Center for AIDS Research (CFAR) from 2001 to 2021.

“I want to thank Jeff for his superb co-leadership of the IDCRC Clinical Operations Unit and his contributions to both COVID-19 and non-COVID-19 clinical trials. We will miss him in the IDCRC and will miss his national leadership in clinical trials and research,” shares David Stephens, MD, IDCRC PI.

A search for a new COU co-director is ongoing, and more information will be announced soon.